However, when we look at the case-only subtype analyses (e.g., ER+ versus ER–, PR+ versus PR–) we see a reduction in the magnitude of the odds ratio suggesting that this region is more likely to be associated generally with the development of breast cancer rather than a particular subtype. The gene discussed is ESR1; the disease is breast cancer.